Chinese Medical E-ournals Database
Adv Search
中华妇幼临床医学杂志(电子版)

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2014, Vol. 10 ›› Issue (06): 757 -761. doi: 10.3877/cma.j.issn.1673-5250.2014.06.013

Special Issue: ； ；

Original Article

Comparative Study of Evaluating Indicators for Cervical Cancer Mass Screening

Lili Han1, Tongxiang Zhao2, Xiaohong Deng3()   

  1. 1. Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026 , China
  • Received:2014-05-15 Revised:2014-10-20 Published:2014-12-01
  • Corresponding author: Xiaohong Deng
  • About author:
    (Corresponding author : Deng Xiaohong,Email : )
HTML ( ) PDF ( )
Objective

To explore the rational and feasible evaluation indicators of mass screening of new-onset cervical cancer.

Methods

A total of 2 092 medical records of new-onset cervical cancer in Beijing from January 2007 to December 2010, as well as cervical cancer incidence and mortality from January 2000 to December 2010 in Beijing were provided by Beijing Office for Cancer Prevention and Control. Meanwhile, the clinical data of mass screening of cervical cancer during the year of 2008 and 2009 were collected from Maternal Child Network Information System. A co-analysis were made retrospectively. The different evaluation indicators (incidence rates, mortality, early stage diagnosis rates, detection rates, participate rates and early diagnosis rates) of cervical cancer screening were compared.

Results

Among 2 092 new-onset cervical cancer patients from January 2007 to December 2010, 1 663 cases (79.49%,1 663/2 092) had a clear clinical stage and 442 cases (26.58%, 442/1 663) were advanced cervical cancer patients. By checking the medical records of advanced cervical cancer of the hospitals and comparing with the data of cervical cancer screening from the year of 2008 and 2009, it showed that 24 cases with advanced cervical cancer participated in the cervical cancer screening, and 5 cases were missed. Those 5 cases mainly concentrated in 4 counties in Beijing. According to the current evaluation indicators of cervical cancer, screening effects of the four counties ranked the forefront among the whole 18 counties.

Conclusions

There are pros and cons between advanced cervical cancer incidence data, incidence rate, mortality, early diagnosis rate, detection rate, participate rate of cervical cancer. But by comparison with the advanced cervical cancer incidence data provided by the hospital medical records and cervical cancer screening data, we can find out misdiagnosed advanced cervical cancer patients, which can evaluate the quality of cervical cancer screening.

Key words: Cervical cancer, Mass screening, Evaluation studies, Indicator
表1 2008 – 2009年度北京市各区县宫颈癌筛查参与率、检出率、早期诊断率分布情况
Table 1 The distribution of participate rates, detection rates and early diagnosis rates of 18 counties between the year of 2008 and 2009
区县 筛查人数（名） 适龄女性人口数（名） 筛查参与率(%) 癌前病变数(例) 宫颈癌（例） 早期宫颈癌(例) 癌前病变及宫颈癌检出率(/10万) 早期诊断率(%)
区县1 13 194 201 314 6.55 7 1 1 60.63 100.00
区县2 27 649 246 023 11.24 55 7 2 224.24 91.94
区县3 8 382 106 757 7.85 8 0 0 95.44 100.00
区县4 18 787 171 283 10.97 14 1 0 79.84 93.33
区县5 121 141 569 408 21.27 140 25 13 136.20 92.73
区县6 83 442 587 160 14.21 48 4 0 62.32 92.31
区县7 63 816 326 788 19.53 12 9 7 32.91 90.48
区县8 25 987 109 994 23.63 28 5 1 126.99 87.88
区县9 13 395 74 217 18.05 23 1 1 179.17 100.00
区县10 72 004 242 740 29.66 12 1 0 18.05 92.31
区县11 53 898 180 659 29.83 10 13 5 42.67 65.22
区县12 26 183 209 058 12.52 2 2 1 15.28 75.00
区县13 72 194 179 074 40.32 41 6 0 65.10 87.23
区县14 30 937 118 058 26.2 13 1 0 45.25 92.86
区县15 46 360 87 051 53.26 47 8 4 118.64 92.73
区县16 22 953 134 740 17.04 7 2 1 39.21 88.89
区县17 11 570 157 624 7.34 3 1 1 34.57 100.00
区县18 16 812 85 801 19.59 43 2 2 267.67 100.00
合计 728 704 3 787 749 19.24 513 89 39 82.61 91.69
表2 北京市各区县宫颈癌筛查效果比较
Table 2 Comparison of the cervical cancer screening effects among different counties in Beijing
区县 癌前病变及宫颈癌检出率排名 筛查参与率排名 早期诊断率排名 晚期宫颈癌患者数（例） 漏诊患者数晚期宫颈癌（例）
区县18 1 8 1 5 1
区县2 2 14 12 7 1
区县9 3 10 2 2 0
区县5 4 7 8 16 2
区县8 5 6 15 1 0
区县15 6 1 9 1 0
区县3 7 16 3 3 0
区县4 8 15 6 1 0
区县13 9 2 16 4 0
区县6 10 12 10 17 1
区县1 11 18 4 4 0
区县14 12 5 7 4 0
区县11 13 3 18 6 0
区县16 14 11 14 3 0
区县17 15 17 5 4 0
区县7 16 9 13 10 0
区县10 17 4 11 7 0
区县12 18 13 17 3 0
图1 北京市宫颈癌发生率和死亡率变化情况（竖线表示2008年与2009年为筛查年度）
Figure 1 Incidence and mortality change of uterine cervical cancer in Beijing (Vertical line means screening year)
[1]
李雪，孔为民，韩超，等.首都医科大学附属北京妇产医院1992 –2011年间宫颈癌发病趋势分析[J/CD].中华妇幼临床医学杂志：电子版，2013，9(3)：310–314.
[2]
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J]. Int J Cancer, 2010, 127 (12) : 2893–2917.
[3]
Tay SK, Ngan HY, Chu TY, et al. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan [J]. Vaccine, 2008, 26 (Suppl 12) : M60–M70.
[4]
郑莹.中国女性癌症预防和控制策略[J].中华预防医学杂志，2013, 47(2):101–104.
[5]
董志伟，乔友林.癌症早诊早治工作评价指标的探讨[J].中国肿瘤，2010，19(10)：633–638.
[6]
韩历丽，齐庆青，王朝，等.：北京市宫颈癌和乳腺癌筛查现况与结果分析[J].中华健康管理学杂志，2011，5 (5)：292–294.
[7]
董志伟，乔友林，王贵齐，等.癌症早诊早治的评价[J].中华肿瘤杂志，2012，34(8)：637–639.
[8]
Maree JE, Wright SC. Cervical cancer: does our message promote screening? A pilot study in a South African context [J]. Eur J Oncol Nurs, 2011, 15(2): 118–123.
[9]
尹畅，李会庆，刁玉涛，等.山东省1 970 – 2005年宫颈癌死亡率变化趋势[J].中国卫生统计，2009，26(4)：347–349.
[10]
Eduardo C, Sue M, Patticia A, et al. Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico[J]. Arch Med Res, 2009, 30 (3) : 240.
[11]
Anttila A, Ronco G, Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE). Description of the national situation of cervical cancer screening in the member states of the European Union [J]. Eur J Cancer, 2009, 45 (15): 2685–2708.
[12]
van der Aa MA, Schutter EM, Looijen-Salamon M, et al. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001 [J]. Eur J Obstet Gynecol Reprod Bol, 2008, 139(2): 204–209.
[13]
韩历丽，齐庆青，王朝，等.北京市宫颈癌筛查费用分析[J].中华医院管理杂志，2011，27(5)：367–368.
[14]
韩历丽，齐庆青，王朝，等.北京市18个区县宫颈癌、乳腺癌检出率比较[J].中国妇幼保健，2011，26(16)：2426–2428.
[15]
de Bie RP, Vergers-Spooren HC, Massuger LF, et al. Patients with cervical cancer : why did screening not prevent these cases? [J]. Am J Obstet Gynecol, 2011, 205(1): 64. e1–e7.
[16]
韩历丽，齐庆青，王朝，等.北京市两癌筛查主要问题与经验探讨[J].实用预防医学，2011，18(3)：566–568.
[17]
Konno R, Shin HR, Kim YT, et al. Human papillomavirus infection and cervical cancer prevention in Japan and Korea [J]. Vaccine, 2008, 26(Suppl 12): M30–M42.
[18]
王春芳，赵丽君，祁文娟，等.妇科门诊患者子宫颈癌认知度和筛查状况分析[J].中国妇产科临床杂志，2012，13 (2)：112–114.
[19]
伍军平，罗新，吴小花.宫颈癌筛查8463例结果分析[J/CD].中华妇幼临床医学杂志：电子版，2011，6(7)：197–201.
[20]
杨忠明，丁显平，庞博，等.人乳头瘤病毒DNA联合液基薄层细胞学检测在宫颈癌筛查诊断中的研究[J].成都医学院学报，2011，6(4):320–323.
[1] Yaqing Zhang, Xuning Huang, Shanshan Xu, Xiaolan Liu. Analysis of quality control indicators for ultrasound medicine in secondary and tertiary hospitals in Hainan Province[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(07): 681-685.
[2] Mei Tang, Li Zhou, Cenyue Niu, Xiaotong Zhou, Qian Wang. Clinical significance of ICG fluorescence guided laparoscopic hepatectomy[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 655-658.
[3] Cuirong Lei, Lifang Ma, Dongling Zou. Minimally invasive surgical technique for excising hypertrophic lymph nodes[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2023, 16(05): 299-303.
[4] Nan Wang, Yuanguang Meng, Bing Ma, Peng Zhang, Wen Yang, Chenglei Gu, Zhifeng Yan, Qingzhi Zhai, Mingxia Li, Zhen Li, Mingyang Wang, Li′an Li. Application of robot surgery in central recurrent cervical cancer[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2023, 16(05): 278-282.
[5] Fujun Liu, Asma Aladoofi, Zhenhua Fu, Qiling Zhang, Lei Yang, Chunhua Tu, Zhi Zhang, Liping Cai. Surgical and oncological outcome of robotic surgery compared with conventional laparotomy in the management of early cervical cancer[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2023, 16(05): 293-298.
[6] Yingying Wang, Kana Wang, Sijing Chen, Na Wang, Ying Zheng. Laparoscopic radical trachelectomy for early cervical cancer[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2022, 15(06): 372-375.
[7] Cankun Zhou, Qingdong Li, Zhuofei Jiang, Lijie Zhao, Yuhua Zheng, Xiaochun Liu, Qinghuang Xie, Xiaobin Huang. Vaginal radical hysterectomy combined with transvaginal endoscopic extraperitoneal lymph node dissection[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2022, 15(06): 368-371.
[8] Ai Jiang, Hongmei Wang, Xiang Kong. miR-15a-5p promotes the proliferation, migration and invasion of cervical cancer cells by targeting HPSE2[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2024, 14(01): 11-18.
[9] Mingming Dong, Zhixin Wang, Qian Zhao. Prognostic value of nutritional indicators for patients with hepatocellular carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(01): 117-120.
[10] Yingpeng Qiu, Xinyu Li, Haibo Qiu, Songqiao Liu, Ling Zhang, Xiangyou Yu, Bingyu Qin, Yingying Pu, Jiayu Zhao, Yongjun Liu, Yue Xiao, Yi Yang. Establishment and validation of quality control index system for continuous renal replacement therapy[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2024, 10(04): 351-357.
[11] Rui Huang, Yuping Wang, Qian Sun, Xiaohong Hou. Analysis of the best evidence of enteral nutrition complicated with diarrhea in ICU patients[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2024, 10(01): 38-41.
[12] Wei Zhao, Xiaofan Li, Haidan Zhao. Longitudinal data analysis of serum uric acid and other biochemical indicators in maintenance hemodialysis patients[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(10): 1064-1070.
[13] Chaodi Li, Juanfang Liu, Su Yan, Shengdong Qin, Haozhe Zhang, Qiongfang Chang, Xinwei Han, Jianhao Zhang. Clinical efficacy analysis of vascular intervention in the treatment of cervical cancer massive hemorrhage[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2024, 12(03): 217-220.
[14] Fengxiang Qi, Xiangjuan Qi. Therapeutic effects of endoscopic submucosal dissection in the treatment of early gastric cancer in elderly patients[J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2023, 10(04): 18-22.
[15] Yulai Yin, Xue Li, Xiangyang He, Xiaoyu Zhang. Body mass index and causal relationships with four characteristic female cancers: a two-sample mendelian randomization study[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2023, 09(04): 253-260.
Viewed
Full text


Abstract

Copyright © Chinese Medical Association, Chinese Medical Multimedia Press  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号